MedTrace Logo

Epicardial vs. Transvenous ICDs in Children

NCT05349162 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 131

Last updated 2022-04-27

No results posted yet for this study

Summary

This observational study included all patients \<18-year-old implanted with an Implantable cardioverter defibrillator (ICD) at Necker Hospital, Paris, France, from January 2003 to January 2021. Outcomes (ICD-related complications and reinterventions) were compared between epicardial and transvenous ICDs using Cox proportional hazard models.

Conditions

  • Implantable Cardioverter Defibrillator Complications
  • Implantable Defibrillator User

Interventions

DEVICE

Implantable cardioverter defibrillator use

Implantation of an implantable cardioverter defibrillator (epicardial or transvenous)

Sponsors & Collaborators

  • Hôpital Necker-Enfants Malades

    collaborator OTHER

  • Paris Cardiovascular Research Center (Inserm U970)

    lead OTHER_GOV

Eligibility

Min Age
0 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-01
Primary Completion
2021-01-01
Completion
2022-04-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05349162 on ClinicalTrials.gov